Congratulations to Matthias Tschöp for receiving the Ernst Jung Prize for Medicine 2021 by the Jung-Stiftung für Wissenschaft und Forschung! 🏅 The prize honors his groundbreaking research on novel therapeutics for #obesity and #diabetes. ‣ bit.ly/3ys84Pq

#ResearchHighlight: #obesity-induced hypothalamic microvascular remodelling precedes increases in blood pressure and contributes to arterial hypertension (£) go.nature.com/2QBs5SL Cristina García Cáceres Matthias Tschöp Tim Gruber IDO @LMU_Uniklinikum Deutsches Zentrum für Diabetesforschung (DZD)

📹One week after Matthias Tschöp received the Ernst Jung Prize for Medicine 2021, here is an inspiring video (in DE) by Jung-Stiftung für Wissenschaft und Forschung where our CEO talks about what ispired him as a scientist and his vision of research and life. Enjoy! 🚀 ‣ shorturl.at/vFR35

Warmest congratulations!!!

❗️New publication in Cell Metabolism❗️ Scientists from the IDO reveal that #astrocytes govern the organization of #bloodvessels in the #hypothalamus depending on #bodyfat stores. Tim Gruber Cristina García Cáceres Matthias Tschöp 👉bit.ly/2SiGlRh

All the best for young scientists in their future endeavours!

🎉Warmest congratulations from the whole IDO team! IDO Helmholtz Diabetes Center (HDC)

❄️The #ClimateCrisis is not just the polar bear with the ice melting under its paws 🥵 It's the hot day that fills hospitals in Europe 🤧 It is the pollen that causes #allergies as early as January ‣ Claudia Traidl-Hoffmann talks about the consequences on our health (in DE) ⤵

We are happy to announce the new 2020 Molecular Metabolism IF: 7⃣.4⃣ ➡️molecularmetabolism.com

📣We are hiring! Timo Müller and team of Molecular Pharmacology at the IDO are looking for enthusiastic scientist for effective drug development in obesity and diabetes. Apply now 👉: jobs.helmholtz-muenchen.de/jobposting/48c…

In Nature Metabolism , scientists from IDO Helmholtz Diabetes Center (HDC) Helmholtz Munich | @HelmholtzMunich and the TU München again highlight the pitfalls of when metabolic rate is divided by body mass: nature.com/articles/s4225…

Anti-obesity drug discovery: advances and challenges | Nature Reviews Drug Discovery nature.com/articles/s4157…

Congratulations to Francesca Alessandrini, Siegfried Ussar, Ruth Karlina et. al. on their latest publication in Allergy EAACI about the "Differential effects of #lung #inflammation on #insulin resistance in humans and mice"! 👏 🔗 bit.ly/3u1vtaN

🏆Two Helmholtz Munich researchers win ERC Consolidator Grants!🏆 👏Congratulations to Ben Engel and Timo Müller! #ERCCoG European Research Council (ERC)

A novel Peptide-Nuclear Hormone conjugate developed by Timo Müller and Novo Nordisk improves #glucose control in preclinical studies with superior efficacy to a pharmacokinetically matched GLP-1 receptor agonist control. 📖Nature Metabolism 🔗t1p.de/nxm3s

Congratulations Timo Müller and team 🥳 Helmholtz Diabetes Center (HDC) diabinfo

📢 The Institute for Diabetes and Obesity (IDO), headed by Timo Müller is looking for a new technical assistant! 🧬 The IDO researches metabolic syndrome diseases using systems biology and translational approaches 🔗 t1p.de/ayyvo

It has been a successful and fruitful year for the IDO. We thank our entire team for their talent, motivation, passion for science, and perseverance. Our Winter Retreat was fantastic 🥳Thank you Helmholtz Munich | @HelmholtzMunich for support 👍

💐Congratulations on the professorship to #HelmholtzMunich expert Timo Müller!